Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT05967416 · RECRUITING

Trial details

NCT number: NCT05967416
Sponsor: SIRPant Immunotherapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Non-Hodgkin Lymphoma Relapsed Non-Hodgkin Lymphoma

Start date: 2024-01-17
Primary completion: 2025-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.